Clinical Trials on Nontraumatic Intracerebral Hemorrhage, Multiple Localized in Japan
Total 135 results
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageJapan
-
Hokkaido University HospitalJapan Agency for Medical Research and DevelopmentRecruiting
-
Joseph Broderick, MDNovo Nordisk A/S; National Institute of Neurological Disorders and Stroke (NINDS)RecruitingIntracerebral HemorrhageUnited States, Canada, Germany, Japan, Spain, United Kingdom
-
University of MinnesotaMedical University of South Carolina; Johns Hopkins University; National Institute... and other collaboratorsTerminatedIntracerebral HemorrhageUnited States, Taiwan, Korea, Republic of, Germany, Japan, Canada, China
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
TakedaCompleted
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Completed
-
CelgeneCompleted
-
Bristol-Myers SquibbCompleted
-
GlaxoSmithKlineActive, not recruiting
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan
-
Eli Lilly and CompanyCompleted
-
SymBio PharmaceuticalsTerminated
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.TerminatedMultiple MyelomaJapan
-
Novartis PharmaceuticalsTerminatedNeoplasms, HaematologicJapan
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Bristol-Myers SquibbCompleted
-
CelgeneCompleted
-
PfizerActive, not recruitingLymphoma | Multiple MyelomaJapan
-
AbbVieActive, not recruiting
-
SymBio PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Bristol-Myers SquibbAbbVieNo longer available
-
Genzyme, a Sanofi CompanyCompleted
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic Syndromes | Multiple MyelomaJapan
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
Celgene CorporationCompleted
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
Novartis PharmaceuticalsCompleted
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
TakedaCompleted
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
CelgeneCompleted
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
Janssen Pharmaceutical K.K.Active, not recruitingHematologic MalignanciesJapan
-
PfizerRecruitingMultiple MyelomaCanada, France, Japan, Australia, United States
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
CelgeneCompletedMultiple MyelomaUnited States, Japan